E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling

Carmen Dominguez-Brauer1, Rahima Khatun2, Andrew J Elia1

  • 1The Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, Ontario M5G 2C1, Canada.

Insights

The protein Mule directly targets beta-catenin for degradation, fine-tuning Wnt signaling. This mechanism acts as a safeguard against tumorigenesis by controlling cell proliferation and stem cell self-renewal.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Wnt signaling is crucial for embryonic development and tissue homeostasis, regulating cell proliferation and stem cell self-renewal.
  • Aberrant Wnt pathway activation, often due to mutations like in APC, drives cancer development, particularly in colon cancer.
  • Mule (also known as Huwe1/Arf-BP1) was previously shown to control intestinal stem cell proliferation via c-Myc modulation of the Wnt pathway.

Purpose of the Study:

  • To investigate the role of Mule in oncogenesis by examining its interaction with beta-catenin.
  • To determine if Mule targets beta-catenin for degradation, especially under conditions of hyperactive Wnt signaling.

Main Methods:

  • Investigated the direct interaction between Mule and beta-catenin.
  • Assessed the degradation of beta-catenin mediated by Mule in the context of Wnt pathway activation.

Main Results:

  • Mule directly interacts with beta-catenin.
  • Mule targets beta-catenin for degradation when the Wnt signaling pathway is hyperactive.
  • These findings indicate Mule's role in regulating beta-catenin stability.

Conclusions:

  • Mule plays a significant role in fine-tuning the Wnt pathway through multiple mechanisms.
  • Mule acts as a critical safeguard against tumorigenesis by controlling key Wnt pathway components.
  • Understanding Mule's function provides insights into potential therapeutic strategies for Wnt-driven cancers.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.8K
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
3.2K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K